Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Alternext  >  Biocorp    ALCOR   FR0012788065

BIOCORP

(ALCOR)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
07/02/2020 07/03/2020 07/06/2020 07/07/2020 07/08/2020 Date
26.8(c) 26.3(c) 25.6(c) 25.4(c) 25.5 Last
3 634 4 819 7 662 8 077 5 889 Volume
+0.75% -1.87% -2.66% -0.78% +0.39% Change
More quotes
Financials
Sales 2020 15,3 M 17,2 M 17,2 M
Net income 2020 0,60 M 0,68 M 0,68 M
Net cash position 2020 1,17 M 1,32 M 1,32 M
P/E ratio 2020 169x
Yield 2020 0,06%
Sales 2021 28,5 M 32,1 M 32,1 M
Net income 2021 8,60 M 9,71 M 9,71 M
Net cash position 2021 11,5 M 12,9 M 12,9 M
P/E ratio 2021 12,2x
Yield 2021 0,83%
Capitalization 105 M 118 M 118 M
EV / Sales 2020 6,80x
EV / Sales 2021 3,28x
Nbr of Employees 52
Free-Float 51,3%
More Financials
Company
Biocorp specializes in the development and manufacture of medical devices and drug delivery systems. The company offers traditional delivery systems, connected injection systems and monitoring devices. Net sales break down by source of income between sales of services (55.4%) and products (44.6%). At the end of 2019, Biocorp has a production site located in France. France accounts for 87.2% of net sales. 
More about the company
Latest news on BIOCORP
06/30BIOCORP : Signs Distribution Agreement for Mallya Technology With Roche Diabetes..
BU
06/22BIOCORP : Announces Initiation of Coverage by Gilbert Dupont
BU
06/19BIOCORP : and Théa Sign a Partnership for the Development of Innovative Digital ..
BU
04/09BIOCORP : 2019 annual results
PU
04/09BIOCORP : 2019 Annual Results
BU
04/09BIOCORP : Annual results
CO
04/06BIOCORP : annual earnings release
02/19BIOCORP : Marketing partnership on Mallya with iSage Rx in the field of digital ..
PU
02/19BIOCORP : Marketing Partnership on Mallya with iSage Rx in the Field of Digital ..
BU
02/12BIOCORP : Strong Revenue Growth In 2019
BU
01/14BIOCORP : and SANOFI Strengthen Their Partnership With Mallya Smart Sensors
BU
01/09BIOCORP : 2020 financial calendar
PU
01/09BIOCORP : 2020 Financial Calendar
BU
01/09BIOCORP : Notices
CO
2019BIOCORP : Changes in BIOCORP's Governance
BU
More news
News in other languages on BIOCORP
07/03BIOCORP : Bilan semestriel du contrat de liquidité BIOCORP confié à la société d..
06/30BIOCORP : unterzeichnet Vertriebsvereinbarung für Mallya-Technologie mit Roche D..
06/30EN DIRECT DES MARCHES : L'Oréal, EDF, Safran, Natixis, Air France, Lucibel, U..
06/30BIOCORP : signe un contrat de distribution de son dispositif connecté Mallya
06/30BIOCORP : contrat de distribution avec Roche Diabetes Care
More news
Chart BIOCORP
Duration : Period :
Biocorp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOCORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 31,35 €
Last Close Price 25,40 €
Spread / Highest target 26,0%
Spread / Average Target 23,4%
Spread / Lowest Target 20,9%
EPS Revisions
Managers
NameTitle
Eric Dessertenne Chief Executive Officer
Jacques Gardette Chairman
Stéphane Chabanais Chief Financial & Administrative Officer
Alain Marcoz Director-Software Research & Development
Emilie Gardette Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOCORP96.90%118
JOHNSON & JOHNSON-1.98%376 352
ROCHE HOLDING AG5.46%299 298
MERCK & CO., INC.-13.45%198 697
NOVARTIS AG-9.58%194 497
PFIZER, INC.-13.14%189 031